Bioactive activities of natural products against herpesvirus infection - PubMed (original) (raw)

Review

Bioactive activities of natural products against herpesvirus infection

Myoungki Son et al. J Microbiol. 2013 Oct.

Erratum in

• J Microbiol. 2013 Dec;51(6):888

Abstract

More than 90% of adults have been infected with at least one human herpesvirus, which establish long-term latent infection for the life of the host. While anti-viral drugs exist that limit herpesvirus replication, many of these are ineffective against latent infection. Moreover, drug-resistant strains of herpesvirus emerge following chemotherapeutic treatment. For example, resistance to acyclovir and related nucleoside analogues can occur when mutations arise in either HSV thymidine kinase or DNA polymerases. Thus, there exists an unmet medical need to develop new anti-herpesvirus agents with different mechanisms of action. In this Review, we discuss the promise of anti-herpetic substances derived from natural products including extracts and pure compounds from potential herbal medicines. One example is Glycyrrhizic acid isolated from licorice that shows promising antiviral activity towards human gammaherpesviruses. Secondly, we discuss anti-herpetic mechanisms utilized by several natural products in molecular level. While nucleoside analogues inhibit replicating herpesviruses in lytic replication, some natural products can disrupt the herpesvirus latent infection in the host cell. In addition, natural products can stimulate immune responses against herpesviral infection. These findings suggest that natural products could be one of the best choices for development of new treatments for latent herpesvirus infection, and may provide synergistic anti-viral activity when supplemented with nucleoside analogues. Therefore, it is important to identify which natural products are more efficacious anti-herpetic agents, and to understand the molecular mechanism in detail for further advance in the anti-viral therapies.

PubMed Disclaimer

Similar articles

• Natural Products and Their Derivatives against Human Herpesvirus Infection.
  Ruchawapol C, Yuan M, Wang SM, Fu WW, Xu HX. Ruchawapol C, et al. Molecules. 2021 Oct 18;26(20):6290. doi: 10.3390/molecules26206290. Molecules. 2021. PMID: 34684870 Free PMC article. Review.
• Bioactive natural products with anti-herpes simplex virus properties.
  Hassan ST, Masarčíková R, Berchová K. Hassan ST, et al. J Pharm Pharmacol. 2015 Oct;67(10):1325-36. doi: 10.1111/jphp.12436. Epub 2015 Jun 9. J Pharm Pharmacol. 2015. PMID: 26060043 Review.
• Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
  Prichard MN, Quenelle DC, Hartline CB, Harden EA, Jefferson G, Frederick SL, Daily SL, Whitley RJ, Tiwari KN, Maddry JA, Secrist JA 3rd, Kern ER. Prichard MN, et al. Antimicrob Agents Chemother. 2009 Dec;53(12):5251-8. doi: 10.1128/AAC.00417-09. Epub 2009 Sep 21. Antimicrob Agents Chemother. 2009. PMID: 19770274 Free PMC article.
• Potential of protein kinase inhibitors for treating herpesvirus-associated disease.
  Li R, Hayward SD. Li R, et al. Trends Microbiol. 2013 Jun;21(6):286-95. doi: 10.1016/j.tim.2013.03.005. Epub 2013 Apr 19. Trends Microbiol. 2013. PMID: 23608036 Free PMC article. Review.
• Broad-spectrum non-nucleoside inhibitors of human herpesviruses.
  McClain L, Zhi Y, Cheng H, Ghosh A, Piazza P, Yee MB, Kumar S, Milosevic J, Bloom DC, Arav-Boger R, Kinchington PR, Yolken R, Nimgaonkar V, D'Aiuto L. McClain L, et al. Antiviral Res. 2015 Sep;121:16-23. doi: 10.1016/j.antiviral.2015.06.005. Epub 2015 Jun 12. Antiviral Res. 2015. PMID: 26079681 Free PMC article.

Cited by

• Natural Products and Their Derivatives against Human Herpesvirus Infection.
  Ruchawapol C, Yuan M, Wang SM, Fu WW, Xu HX. Ruchawapol C, et al. Molecules. 2021 Oct 18;26(20):6290. doi: 10.3390/molecules26206290. Molecules. 2021. PMID: 34684870 Free PMC article. Review.
• Causality between herpes virus infections and allograft dysfunction after tissue and organ transplantation: a two-sample bidirectional Mendelian randomization study.
  Qiu X, Ma T, Zhao S, Zheng Z. Qiu X, et al. Front Immunol. 2024 Aug 14;15:1411771. doi: 10.3389/fimmu.2024.1411771. eCollection 2024. Front Immunol. 2024. PMID: 39211049 Free PMC article.
• A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
  Kaneko M, Watashi K, Kamisuki S, Matsunaga H, Iwamoto M, Kawai F, Ohashi H, Tsukuda S, Shimura S, Suzuki R, Aizaki H, Sugiyama M, Park SY, Ito T, Ohtani N, Sugawara F, Tanaka Y, Mizokami M, Sureau C, Wakita T. Kaneko M, et al. J Virol. 2015 Dec;89(23):11945-53. doi: 10.1128/JVI.01855-15. Epub 2015 Sep 16. J Virol. 2015. PMID: 26378168 Free PMC article.
• In Vitro Anti-HSV-1 Activity of Polyphenol-Rich Extracts and Pure Polyphenol Compounds Derived from Pistachios Kernels (Pistacia vera L.).
  Musarra-Pizzo M, Pennisi R, Ben-Amor I, Smeriglio A, Mandalari G, Sciortino MT. Musarra-Pizzo M, et al. Plants (Basel). 2020 Feb 18;9(2):267. doi: 10.3390/plants9020267. Plants (Basel). 2020. PMID: 32085514 Free PMC article.
• Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins.
  Maffei ME, Salata C, Gribaudo G. Maffei ME, et al. Molecules. 2022 Nov 30;27(23):8353. doi: 10.3390/molecules27238353. Molecules. 2022. PMID: 36500445 Free PMC article. Review.

References

1. 1. Antiviral Res. 2010 Mar;85(3):490-5 - PubMed
2. 1. J Virol. 2011 Nov;85(21):11159-69 - PubMed
3. 1. J Microbiol. 2013 Aug;51(4):490-8 - PubMed
4. 1. Cancer Lett. 1997 May 19;115(2):173-8 - PubMed
5. 1. Mem Inst Oswaldo Cruz. 2002 Jun;97(4):541-6 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • scite Smart Citations